Catalytic 1,4-Rhodium(III) Migration Enables 1,3-Enynes to Function as One-Carbon Oxidative Annulation Partners in C–H Functionalizations**

por Burns, David J, Lam, Hon Wai
Publicado 2014

Direct Synthesis of 5-Aryl Barbituric Acids by Rhodium(II)-Catalyzed Reactions of Arenes with Diazo Compounds**

por Best, Daniel, Burns, David J, Lam, Hon Wai
Publicado 2015

All-Carbon [3+3] Oxidative Annulations of 1,3-Enynes by Rhodium(III)-Catalyzed C–H Functionalization and 1,4-Migration**

por Burns, David J, Best, Daniel, Wieczysty, Martin D, Lam, Hon Wai
Publicado 2015

Enantioselective Synthesis of Spiroindenes by Enol-Directed Rhodium(III)-Catalyzed C–H Functionalization and Spiroannulation

por Reddy Chidipudi, Suresh, Burns, David J, Khan, Imtiaz, Lam, Hon Wai
Publicado 2015

Direct Hydrodecarboxylation of Aliphatic Carboxylic Acids: Metal- and Light-Free

por McLean, Euan B., Mooney, David T., Burns, David J., Lee, Ai-Lan
Publicado 2022

Ruthenium(II)-catalysed remote C–H alkylations as a versatile platform to meta-decorated arenes

por Li, Jie, Korvorapun, Korkit, De Sarkar, Suman, Rogge, Torben, Burns, David J., Warratz, Svenja, Ackermann, Lutz
Publicado 2017

Functional signaling test identifies HER2 negative breast cancer patients who may benefit from c-Met and pan-HER combination therapy

por MacNeil, Ian A., Khan, Salmaan A., Sen, Adrish, Soltani, Sajjad M., Burns, David J., Sullivan, Brian F., Laing, Lance G.
Publicado 2022

Development of a test that measures real-time HER2 signaling function in live breast cancer cell lines and primary cells

por Huang, Yao, Burns, David J., Rich, Benjamin E., MacNeil, Ian A., Dandapat, Abhijit, Soltani, Sajjad M., Myhre, Samantha, Sullivan, Brian F., Lange, Carol A., Furcht, Leo T., Laing, Lance G.
Publicado 2017

New HER2-negative breast cancer subtype responsive to anti-HER2 therapy identified

por MacNeil, Ian A., Burns, David J., Rich, Benjamin E., Soltani, Sajjad M., Kharbush, Samantha, Osterhaus, Nicole G., Sullivan, Brian F., Hawkins, Douglas M., Pietruska, Jodie R., Laing, Lance G.
Publicado 2020

A functional signal profiling test for identifying a subset of HER2-negative breast cancers with abnormally amplified HER2 signaling activity

por Huang, Yao, Burns, David J, Rich, Benjamin E, MacNeil, Ian A, Dandapat, Abhijit, Soltani, Sajjad M., Myhre, Samantha, Sullivan, Brian F, Furcht, Leo T, Lange, Carol A, Hurvitz, Sara A, Laing, Lance G
Publicado 2016